MILAN, Apr. 29 (Class Editori) - PharmaNutra strengthens the distribution of its products in Asia, Central-Eastern Europe and Mexico. The pharmaceutical company, through its subsidiary Junia Pharma, specialized in the development of drugs and nutritional supplements for the pediatric sector, has signed an agreement with Green Store, to distribute a new and innovative iron-based formulation.
"The distribution agreements in South Korea and Mexico are particularly relevant, not only because they are very large markets in which we consolidate our presence, but because the stipulation ended in a complicated period, after the spread of the COVID-19 emergency", explained the managing director of the company listed on the AIM, Carlo Volpi. "In recent months, the companies of the group have never stopped. Having signed agreements so important, in such a difficult moment, is a satisfaction that we want to share with all our employees and collaborators". In Mexico, the pharmaceutical group has moved through Junia Pharma in agreement with Casa Marzam, a leading company in the local pharmaceutical sector.
At the same time, PharmaNutra moved on the markets in Europe. In Romania through an agreement with Sc Solacium, a company of the Zentiva group, already a partner of PharmaNutra since 2016 for the marketing of SiderAL (supplement based on Sucrosomal Iron) for the markets of the Czech Republic and Slovakia. "It's about expanding a close and profitable partnership," explains a note. The second agreement was signed with Fresenius Kabi for the distribution of SiderAL Forte in Hungary, thus allowing PharmaNutra to complete its presence in Central Europe.
"A very important agreement that consolidates the relationship with a high-level pharmaceutical multinational with whom we already collaborate in Austria and Switzerland," adds Volpi. "It is the confirmation of a commercial partnership, based on a strong and common intent and vision: with Fresenius Kabi we are in fact working on expanding the collaboration also in other important countries".
(Source:Class Editori)
Notice: No person, organization and/or company shall disseminate or broadcast the above article on Xinhua Silk Road website without prior permission by Xinhua Silk Road.
A single purchase
